Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

30.57 -0.14 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
A Closer Look at TG Therapeutics's Options Market Dynamics ↗
 
Via Benzinga
News headline image
NASDAQ:TGTX: a strong growth stock preparing for the next leg up?. ↗
TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating. 
Via Chartmill
News headline image
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review ↗
After Monday's panicked global sell-off, markets have calmed down. 
Via Investor's Business Daily
News headline image
NASDAQ:TGTX is showing decent growth, but is still valued reasonably. ↗
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank. 
Via Chartmill
News headline image
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates ↗
 
Via Benzinga
Topics Earnings Stocks
News headline image
$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
(TGTX) - Analyzing TG Therapeutics's Short Interest ↗
 
Via Benzinga
News headline image
Peering Into TG Therapeutics's Recent Short Interest ↗
 
Via Benzinga
News headline image
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
TGTX stock results show that TG Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157% ↗
The company unexpectedly reported profit in the second quarter, handily beating views for a per-share loss. 
Via Investor's Business Daily
News headline image
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗
Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX). 
Via Chartmill
News headline image
(TGTX) - Analyzing TG Therapeutics's Short Interest ↗
 
Via Benzinga
News headline image
Earnings Preview For TG Therapeutics ↗
 
Via Benzinga
News headline image
"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker ↗
Our first-ever twin bill. 
Via The Motley Fool
News headline image
Nasdaq 100 Overbought? Here’s What History Says About The Current Rally ↗
Find out the historical patterns traders can look for to anticipate the next move in the Nasdaq 100. 
Via Talk Markets
News headline image
The Most Shorted Stocks in June: Hold, Short, or Squeeze?
Given the proper catalyst, the short interest in these stocks may lead to a short squeeze. All the market needs is a push and it may come at any time. 
Via MarketBeat
News headline image
Why TG Therapeutics Stock Was Rocketing Higher This Week ↗
The company raised guidance for sales of its drug for relapsing multiple sclerosis. 
Via The Motley Fool
News headline image
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗
TGTX stock results show that TG Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
TG Therapeutics stock just rallied 30%: what happened? ↗
TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. 
Via Talk Markets
News headline image
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
From FN Media Group LLC
Via GlobeNewswire
News headline image
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today? ↗
TG Therapeutics exceeds expectations with Q4 2023 revenues of $43.97M. Briumvi's success in the U.S., Europe launch, and new patents drive optimism. TGTX shares surge 
Via Benzinga
Topics Intellectual Property
News headline image
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
News headline image
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? ↗
The company reported in-line sales for the fourth quarter, but shares soared by double digits. 
Via Investor's Business Daily
News headline image
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For February 28, 2024 ↗
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.